These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Leukocytoclastic vasculitis associated with naproxen]. Lossos IS, Yossepowitch O, Amir G, Orren R. Harefuah; 1996 May 01; 130(9):600-1, 655. PubMed ID: 8794637 [Abstract] [Full Text] [Related]
5. Cutaneous vasculitis: diagnosis and management. Carlson JA, Cavaliere LF, Grant-Kels JM. Clin Dermatol; 2006 May 01; 24(5):414-29. PubMed ID: 16966021 [Abstract] [Full Text] [Related]
6. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS. Am J Gastroenterol; 2001 Apr 01; 96(4):1019-27. PubMed ID: 11316141 [Abstract] [Full Text] [Related]
7. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature. Kalksma R, Jansen TL, Bruyn GA. Neth J Med; 2002 Aug 01; 60(7):289-91. PubMed ID: 12430576 [Abstract] [Full Text] [Related]
8. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Carlson JA, Chen KR. Am J Dermatopathol; 2006 Dec 01; 28(6):486-506. PubMed ID: 17122493 [Abstract] [Full Text] [Related]
14. Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study. Wijnands M, van Riel P, van 't Hof M, Gribnau F, van de Putte L. J Rheumatol; 1991 Feb 01; 18(2):184-7. PubMed ID: 2023212 [Abstract] [Full Text] [Related]